Vyleesi® product results: 14% growth in prescriptions dispensed over prior quarter – 7 consecutive quarters of double digit growth. Click here to learn more ›

Palatin Technologies, Inc. To Report Fiscal Year 2013 Fourth Quarter Results

CRANBURY, N.J., Sept. 25, 2013 /PRNewswire/ — Palatin Technologies, Inc. (NYSE MKT: PTN) will announce its fourth quarter, fiscal year 2013 operating results on Monday, September 30, 2013 after the close of the U.S. financial markets.

Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on October 1, 2013 at 10:00 a.m. ET. The conference call will include a review on the company’s operating results and an update on programs under development.

Schedule for the Operating Results Press Release, Conference Call / Webcast

Q4 & Fiscal Year 2013 Financial Results Press Release      

9/30/2013 at 4:30 p.m. ET

Q4 & Fiscal Year 2013 Conference Call-Live        

10/1/2013 at 10:00 a.m. ET

Domestic Dial-In Number                               


International Dial-In Number                         




Q4 & Fiscal Year 2013 Conference Call-Replay                


Domestic Dial-In Number                                           


International Dial-In Number                                     




Webcast Live and Replay Access                    


The webcast and replay can be accessed by logging on to the “Investor/Media Center-Webcasts” section of Palatin’s website at http://www.palatin.com

About Palatin Technologies, Inc.
Palatin Technologies, Inc. is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Palatin’s strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. For additional information, please visit http://www.palatin.com or follow us on Twitter at http://twitter.com/PalatinTech.

SOURCE Palatin Technologies, Inc.

Scroll to Top